EASYTIDES RADIOACTIVE REAGENTS - MOLECULAR DIAGNOSTIC LABORATORY

This tender concerns the procurement of "EASYTIDES" radioactive reagents for the Molecular Diagnostic Laboratory. The contracting authority is CHU de Québec-Université Laval, a leading university hospital center. These reagents are classified under Medical Supplies and Equipment, specifically as reagents for DNA sequence analyzers. The procurement method is a negotiated contract, justified by Article 14, indicating that the contract value is below the threshold requiring a public tender. This allows for a more streamlined acquisition process for these specialized laboratory consumables. The "EASYTIDES" reagents are crucial for molecular diagnostic testing, likely involving the analysis of genetic material for disease detection, research, or personalized medicine. The Molecular Diagnostic Laboratory plays a vital role in healthcare, and the consistent availability of high-quality reagents is essential for accurate and timely diagnostic results. This tender ensures that the laboratory is equipped with the necessary materials to perform its critical functions, supporting patient diagnosis and treatment within the healthcare system.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Laboratory and Medical Equipment. Located in Canada, North America, this opportunity is open to firms and consortiums.

Published through Quebec SEAO, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.